REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) Form 8-K — May 13, 2026
$RVPHForm 8-KItems 2.02, 7.01, 9.01Filed May 13, 2026, 4:41 PM ET0001437749-26-016760Original filing
Reviva Pharmaceuticals Holdings, Inc. reported a net loss of $3.2 million, or $0.46 per share, for the first quarter of 2026, a significant improvement from the $6.4 million, or $2.61 per share, net loss in the same period of 2025. The company's cash and cash equivalents increased to $22.2 million as of March 31, 2026, from $14.4 million as of December 31, 2025. Reviva has filed a U.S.
Key figures
- Eps
- -0.46
- Net Income
- -3,195,987
- Cash Position
- 22,190,231
- Shares Outstanding
- 7,022,945
- Reverse split ratio
- 1:20
Price after filing
1 day: 0.0%7 days: 0.0%30 days: +94.2%
Close on the filing date to close N calendar days later (from $0.35). Historical, not a forecast.
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.